Inspire Investing
DYN icon

Inspire Investing’s Dyne Therapeutics DYN Stock Holding History

Inspire Investing’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$80 Sell
5
-463
-99% -$10.6K ﹤0.01% 1244
2026
Q2 		$10.4K Sell
468
-8,835
-95% -$164K ﹤0.01% 1116
2026
Q1 		$169K Buy
+9,303
New +$160K 0.01% 888
2023
Q2 		– Sell
-39,722
Closed -$458K – 800
2023
Q1 		$458K Buy
+39,722
New +$516K 0.06% 253

Other funds holding DYN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Inspire Investing's DYN Position: Q3 2026 in Review

Inspire Investing reduced its Dyne Therapeutics (DYN) stake by 99% in Q3 2026, selling an estimated $10.6K and leaving 5 shares worth $80. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Inspire Investing first reported a position in DYN in Q1 2023 and has held it in 4 quarters since. The position peaked at $458K in Q1 2023. 109 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • Inspire Investing held 5 shares of Dyne Therapeutics worth $80 as of Q3 2026.
  • Inspire Investing sold 463 Dyne Therapeutics shares in Q3 2026, an estimated $10.6K.
  • Dyne Therapeutics made up ﹤0.01% of Inspire Investing's portfolio in Q3 2026, its #1244 holding.
  • Inspire Investing first reported a position in Dyne Therapeutics in Q1 2023 and has held it in 4 quarters since.
  • Inspire Investing's Dyne Therapeutics position peaked at $458K in Q1 2023.
  • 109 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.